Related Experiment Videos

[Malignant disorders of the lymphatic system]

J C Kluin-Nelemans, R L Bolhuis, B Löwenberg

Nederlands Tijdschrift Voor Geneeskunde

|December 6, 1986

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Addition of the nuclear export inhibitor selinexor to standard intensive treatment for elderly patients with acute myeloid leukemia and high risk myelodysplastic syndrome.

Leukemia·2022

Correction: Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS.

Leukemia·2020

Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS.

Leukemia·2020

Distinct factors determine the kinetics of disease relapse in adults transplanted for acute myeloid leukaemia.

Journal of internal medicine·2017

Long-term outcome of older patients with newly diagnosed de novo acute promyelocytic leukemia treated with ATRA plus anthracycline-based therapy.

Leukemia·2017

Comparative value of post-remission treatment in cytogenetically normal AML subclassified by NPM1 and FLT3-ITD allelic ratio.

Leukemia·2016

See all related articles